Mahamaya Lifesciences Limited
Nav Capital decreased its stake in Mahamaya Lifesciences Limited from 2.53% to 1.73%, reducing its holding from 5,91,600 shares to 4,04,400 shares through a rights issue.
A manufacturer and exporter of crop protection products and bioproducts, Mahamaya Lifesciences operates in the agrochemicals and pesticides sector since its incorporation in 2002. The company specializes in developing and registering formulations for crop and soil health management, serving agricultural markets through its portfolio of finest crop protection solutions designed to enhance farm productivity and sustainability.
Nav Capital is an India-focused investment platform whose Nav Capital VCC Emerging Star Fund is among the most active foreign portfolio investors anchoring Indian SME IPOs. It pursues high-conviction investing across private and public markets.